ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Clinical Practice Session

Controversy Conference: KDIGO Target for Systolic BP in CKD of <120 mm Hg

November 05, 2021 | 02:00 PM - 04:00 PM

Location: Live-Stream, Virtual Only

Session Description

KDIGO issued a revised guideline for the management of high BP in CKD in February 2021, including the recommendation to target a systolic BP <120 mm Hg using standard office BP measurements. Public review of the guideline in early 2020 elicited some criticism of this particular recommendation. This session reviews the pros and cons of the major recommendations.

Learning Objective(s)

  • Discuss the importance of how BP is measured in CKD
  • Describe the benefits and risks of using <120 mm Hg as the target systolic BP in CKD
  • Discuss methods of treating high BP in CKD

Learning Pathway(s)

  • Hypertension and CVD
  • Chronic Kidney Disease

Moderators

  • Debbie L. Cohen, MD, FASN
  • Sandra J. Taler, MD

Presentations

  • Measuring Standard Office BP Is Necessary and Feasible: Pro
    02:00 PM - 02:30 PM
    Tara I. Chang, MD, MS, FASN
  • Measuring Standard Office BP Is Necessary and Feasible: Con
    02:30 PM - 03:00 PM
    Indranil Dasgupta, MBBS, MD
  • Targeting Systolic BP <120 mm Hg in CKD Is Beneficial: Pro
    03:00 PM - 03:30 PM
    Joachim H. Ix, MD, FASN
  • Targeting Systolic BP <120 mm Hg in CKD Is Beneficial: Con
    03:30 PM - 04:00 PM
    George L. Bakris, MD, FASN